Physician

Bruce Mullen, MD

According to 2025 Medicare claims, Bruce Mullen, MD (NPI: 1083781702) practices physical medicine and rehabilitation in the Carson City, NV market, with the plurality of this provider's patient population coming from Carson City, NV. This provider's primary affiliated billing organization is BRUCE E MULLEN A PROFESSIONAL CORPORATION (NPI: 1750331013; TIN: 880396454) and primary practice location at 89701-3107.

Mullen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 254 traditional Medicare patients, billed 3,823 HCPCS/CPT codes, and received $251,347 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,056 prescription claims across 395 beneficiaries totaling $157,975 in drug costs, led by Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl). Open Payments data shows 68 records totaling $1,824. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $513,900 to $157,975. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	397	3,355	$287,925
2016	474	3,503	$290,186
2017	410	3,453	$317,781
2018	378	3,460	$276,402
2019	412	4,857	$347,281
2020	423	3,649	$313,211
2021	396	2,508	$282,741
2022	415	3,556	$327,068
2023	341	4,734	$290,236
2024	254	3,823	$251,347

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	341	6,223	$513,900
2016	381	5,937	$490,390
2017	349	6,115	$481,912
2018	331	5,061	$400,307
2019	320	4,351	$293,210
2020	281	2,310	$107,737
2021	349	2,894	$148,000
2022	405	3,344	$179,645
2023	377	2,594	$155,235
2024	395	3,056	$157,975

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	205	708	$90
99426	Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month	113	606	$48
99457	Management using the results of remote vital sign monitoring per calendar month, first 20 minutes	104	411	$38
99427	Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month	106	546	$37
99458	Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes	101	611	$31

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	282	8,460	$41,936
Nurtec Odt	Rimegepant Sulfate	14	416	$19,968
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	561	16,214	$14,181
Suboxone	Buprenorphine Hcl/Naloxone Hcl	13	390	$7,831
Xtampza Er	Oxycodone Myristate	14	420	$7,576

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	68	$1,824	Saluda Medical Americas, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bruce Mullen, MD?

Tedicare shows public-source Medicare data for Bruce Mullen, MD (NPI 1083781702), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bruce Mullen, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Bruce Mullen, MD?

Bruce Mullen, MD is linked to BRUCE E MULLEN A PROFESSIONAL CORPORATION (billing NPI 1750331013) in the available physician profile data.

Does Bruce Mullen, MD have Open Payments data?

Bruce Mullen, MD has 68 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.